【Date&Time】Oct.9(Wed.) 13:00~15:30

【Venue】Room F205+206, Annex Hall Pacifico Yokohama

To Pre-register for the seminars, please complete the visitor registration first.

*If you already completed above, you can proceed your seminar registration
from your visitor account.

Challenges in New Fields of the Pharmaceutical Industry and the Medical Device Industry
- New Business Potential as Companies from Other Industries Enter the Field

A bolder and more radical approach is becoming the new business model in the pharmaceutical and medical device industry, as pharma and medical device companies are expanding their businesses into preventive and general healthcare services, while non-medical companies are increasingly more interested in drug and medical device development. This symposium will introduce these nonconventional movements with real-life examples, followed by a panel discussion to explore the possible developments and challenges we might face.

各登壇者は2019年9月30日現在のものです。
今後予告なく変更になる場合があります。ご了承ください。

Part1

Opening Remarks
Ministry of Health, Labour and Welfare

Lecture

Global Head, World Without Disease Accelerator,
Janssen Pharmaceutical Companies of Johnson & Johnson

Benjamin Wiegand

Global Head of Digital Strategy and Program Operations,
Novartis International AG

Thorsten Rall

CTO, Microsoft Japan Co., Ltd.
/ President, Microsoft Development Co., Ltd.

Akira Sakakibara

各登壇者は2019年9月30日現在のものです。
今後予告なく変更になる場合があります。ご了承ください。

Part2

Venture Support Initiatives of the Ministry of Health,Labour and Welfare
Taihei Tanaka
Director, Venture Support Strategy Office, Economic Affairs Division,
Health Policy Bureau, Ministry of Health, Labour and Welfare

Panel Discussion

[Moderator]

Managing Director, Honjo International
/ Chairperson of the Council for Fostering Medical Ventures

Shuji Honjo

[Panelists]

Global Head, World Without Disease Accelerator,
Janssen Pharmaceutical Companies of Johnson & Johnson

Benjamin Wiegand

Global Head of Digital Strategy and Program Operations,
Novartis International AG

Thorsten Rall

CTO, Microsoft Japan Co., Ltd.
/ President, Microsoft Development Co., Ltd.

Akira Sakakibara

The University of Tokyo Edge Capital co.,Ltd.
/ The University of Tokyo Edge Capital Partners Co., Ltd. (UTEC)
Managing Partner and President

Tomotaka Goji

Director, Venture Support Strategy Office,
Economic Affairs Division, Health Policy Bureau,
Ministry of Health, Labour and Welfare

Taihei Tanaka